A randomized controlled trial on the treatment of primary Sjögren syndrome with yin deficiency and dryness-heat pattern with Bushen Qingre Runzao Decoction
Special Theme: TCM Prevention and Treatment of Rheumatism|更新时间:2023-12-08
|
A randomized controlled trial on the treatment of primary Sjögren syndrome with yin deficiency and dryness-heat pattern with Bushen Qingre Runzao Decoction
Journal of Beijing University of Traditional Chinese MedicineVol. 46, Issue 11, Pages: 1490-1498(2023)
作者机构:
1.北京中医药大学研究生院 北京 100029
2.中日友好医院中医风湿病科
3.免疫炎性疾病北京市重点实验室
作者简介:
LUO Jing, Ph.D., Attending Physician. China-Japan Friendship Hospital, No.2, Yinghuayuan East Road, Chaoyang District, Beijing 100029. E-mail: luojinggg@sina.com
基金信息:
Capital Funds for Health Developement and Research(2020-4-40610)
CHEN Jiaqi, YANG Jianying, ZHANG Yan, et al. A randomized controlled trial on the treatment of primary Sjögren syndrome with yin deficiency and dryness-heat pattern with Bushen Qingre Runzao Decoction[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(11): 1490-1498. DOI: 10.3969/j.issn.1006-2157.2023.11.002.
DOI:
CHEN Jiaqi, YANG Jianying, ZHANG Yan, et al. A randomized controlled trial on the treatment of primary Sjögren syndrome with yin deficiency and dryness-heat pattern with Bushen Qingre Runzao Decoction[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(11): 1490-1498. DOI: 10.3969/j.issn.1006-2157.2023.11.002.DOI:
A randomized controlled trial on the treatment of primary Sjögren syndrome with yin deficiency and dryness-heat pattern with Bushen Qingre Runzao Decoction
This study aimed to evaluate the efficacy and safety of
Bushen Qingre Runzao
Decoction (rehmanniae radix
ophiopogonis radix
dendrobii caulis
moutan cortex
lophatheri herba
forsythiae fructus
mori folium
and amomi fructus) in treating primary Sjögren syndrome (PSS) with yin deficiency and dryness-heat pattern.
Methods
2
A randomized controlled trial was conducted. PSS patients with yin deficiency and dryness-heat pattern who were admitted to TCM Department of Rheumatism of China-Japan Friendship Hospital from September 2020 to January 2023
were enrolled. Patients were randomized 1∶1 into the treatment and control groups. The treatment group was treated with
Bushen Qingre Runzao
Decoction
and the control group was administered hydroxychloroquine sulfate tablets. The duration of intervention in both groups was 12 weeks. The differences in Vision Analog Scale (VAS) scores of dry mouth
dry eyes
fatigue
body pain
overall dry symptoms
and European League Against Rheumatism (EULAR) Sjögren Syndrome Patient-Reported Index (ESSPRI)
Sjögren Syndrome Disease Activity Index (ESSDAI)
salivary flow rate
Schirmer’s test
and immune inflammation index [serum immunoglobulins (IgG
IgA
IgM)
complements(C3
C4)
erythrocyte sedimentation rate
C-reactive protein] between the two groups were compared
and adverse reactions were observed.
Results
2
A total of 96 patients were included
with 48 cases per group. After 12 weeks of intervention
the VAS scores of dry mouth
dry eyes
and overall dryness symptoms were lower in the treatment group than those in the control group (all
P
<
0.05). In the treatment group
after 12 weeks of intervention
the VAS scores of dry mouth
dry eyes
and overall dryness symptoms and ESSPRI were significantly lower than those before treatment (all
P
<
0.05)
and the Schirmer’s test result and health change scores of SF-36 were significantly higher than those before treatment (both
P
<
0.01). In the control group
after 12 weeks of intervention
the VAS score of fatigue(
P
<
0.01) was lower than that before treatment
and serum levels of IgA
C3
C4
and health change score of SF-36 were higher than those before treatment(all
P
<
0.05). There was only one case of diarrhea and one case of loose stool in the experimental group
and one case of rash and one case of skin color darkening in the control group. No serious adverse reactions were observed in both groups.
Conclusion
2
Bushen Qingre Runzao
Decoction has a high safety profile and can effectively improve dryness symptoms such as dry mouth and eyes and increase tear secretion in PSS patients with yin deficiency and dryness-heat pattern.
RAMOS-CASALS M , BRITO-ZERÓN P , BOMBARDIERI S , et al . EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies [J]. Ann Rheum Dis , 2020 , 79 ( 1 ): 3 - 18 .
SHIBOSKI CH , SHIBOSKI SC , SEROR R , et al . 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts [J]. Arthritis Rheumatol , 2017 , 69 ( 1 ): 35 - 45 .
HUI M , CARR A , CAMERON S , et al . The British Society for Rheumatology Guideline for the Management of Gout [J]. Rheumatology (Oxford) , 2017 , 56 ( 7 ): e1 - e20 .
FOX RI , FOX CM , GOTTENBERG JE , et al . Treatment of Sjögren’s syndrome:current therapy and future directions [J]. Rheumatology (Oxford) , 2021 , 60 ( 5 ): 2066 - 2074 .
ZHANG T , SHAN HL , QIAN B , et al . Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositis [J/OL]. Front Pharmacol , 2017 , 8 : 786 [ 2022-10-09 ]. https://www.frontiersin.org/articles/10.3389/fphar.2017.00786/full .
YOON CH , LEE HJ , LEE EY , et al . Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren’s Syndrome:a Double-Blind Randomized Control Study [J]. J Korean Med Sci , 2016 , 31 ( 7 ): 1127 - 1135 .
GOTTENBERG JE , RAVAUD P , PUÉCHAL X , et al . Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial [J]. JAMA , 2014 , 312 ( 3 ): 249 - 258 .
NG WF , BOWMAN SJ . Primary Sjogren’s syndrome:too dry and too tired [J]. Rheumatology (Oxford) , 2010 , 49 ( 5 ): 844 - 853 .
KRUIZE AA , HENÉ RJ , KALLENBERG CG , et al . Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial [J]. Ann Rheum Dis , 1993 , 52 ( 5 ): 360 - 364 .
PU A , LEE DSW , ISHO B , et al . The Impact of IgA and the Microbiota on CNS Disease [J/OL]. Front Immunol , 2021 , 12 : 742173 [ 2022-10-09 ]. https://www.frontiersin.org/articles/10.3389/fimmu.2021.742173/full .
Shugan Dingji Granules for treating paroxysmal atrial fibrillation with liver qi stagnation syndrome
Ditan Qingnao Formula for treating negative symptoms of schizophrenia with marrow-deficiency and phlegm-obscuring pattern: a randomized double-blind controlled trial
Effect of disease duration on the efficacy of acupuncture for discogenic sciatica: a secondary analysis of a multicenter randomized controlled trial
Clinical study of Hewei Jiangni Formula in patients with non-erosive gastroesophageal reflux disease and cold-heat complex syndrome
Clinical study on the immediate and short-term therapeutic effects of Shexiang Tongxin Dripping Pill on improving coronary slow flow
Related Author
QIAO Siyu
DENG Bing
WANG Yun
ZHANG Shuai
REN Weiwei
SHEN Lin
ZHANG Yi
WU Bin
Related Institution
Minhang District Hospital of Integrated Traditional Chinese and Western Medicine
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Miyun District Hospital of Traditional Chinese Medicine
Beijing University of Chinese Medicine
Sichuan Guangyuan Hospital of Traditional Chinese Medicine